BRPI0418310A - linhagem de células-tronco embrionárias, método de preparação da mesma, neuro-progenitor, método de preparação do mesmo e meio de cultura - Google Patents

linhagem de células-tronco embrionárias, método de preparação da mesma, neuro-progenitor, método de preparação do mesmo e meio de cultura

Info

Publication number
BRPI0418310A
BRPI0418310A BRPI0418310-0A BRPI0418310A BRPI0418310A BR PI0418310 A BRPI0418310 A BR PI0418310A BR PI0418310 A BRPI0418310 A BR PI0418310A BR PI0418310 A BRPI0418310 A BR PI0418310A
Authority
BR
Brazil
Prior art keywords
preparation
embryonic stem
cell line
stem cell
culture medium
Prior art date
Application number
BRPI0418310-0A
Other languages
English (en)
Inventor
Sung-Ii Roh
Woo-Suk Hwang
Byenog-Chun Lee
Sung-Keun Kang
Young-June Ryu
Eu-Gene Lee
Soon-Woog Kim
Dae-Kee Kwon
Hee-Sun Kwon
Ja-Min Koo
Eul-Soon Park
Youn-Young Hwang
Shin-Yong Moon
Sun-Kyung Oh
Cu-Rie Ahn
Hyun-Soo Yoon
Jong-Hyuk Park
Sun-Jong Kim
Yang-Kyu Choi
Original Assignee
Seoul Nat Univ Ind Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34737817&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0418310(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Seoul Nat Univ Ind Foundation filed Critical Seoul Nat Univ Ind Foundation
Publication of BRPI0418310A publication Critical patent/BRPI0418310A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0606Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877Techniques for producing new mammalian cloned embryos
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877Techniques for producing new mammalian cloned embryos
    • C12N15/8776Primate embryos
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0619Neurons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • C12N2500/25Insulin-transferrin; Insulin-transferrin-selenium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/40Nucleotides, nucleosides or bases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/13Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • C12N2501/235Leukemia inhibitory factor [LIF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0623Stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

LINHAGEM DE CéLULAS-TRONCO EMBRIONáRIAS, MéTODO DE PREPARAçãO DA MESMA, NEURO-PROGENITOR, MéTODO DE PREPARAçãO DO MESMO E MEIO DE CULTURA A presente invenção refere-se a uma linhagem de células-tronco embrionárias, derivada de um oócito com núcleo transferido, preparado pela tranferência do núcleo de uma célula somática para um oócito humano sem núlcleo, para a diferenciação em diversos tipos desejados de células.
BRPI0418310-0A 2003-12-30 2004-12-30 linhagem de células-tronco embrionárias, método de preparação da mesma, neuro-progenitor, método de preparação do mesmo e meio de cultura BRPI0418310A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR0302899 2003-12-30
PCT/KR2004/003528 WO2005063972A1 (en) 2003-12-30 2004-12-30 Embryonic stem cell line and method for preparing the same

Publications (1)

Publication Number Publication Date
BRPI0418310A true BRPI0418310A (pt) 2007-05-02

Family

ID=34737817

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418310-0A BRPI0418310A (pt) 2003-12-30 2004-12-30 linhagem de células-tronco embrionárias, método de preparação da mesma, neuro-progenitor, método de preparação do mesmo e meio de cultura

Country Status (12)

Country Link
US (4) US20070243610A1 (pt)
EP (1) EP1711599B1 (pt)
JP (1) JP2007516720A (pt)
KR (2) KR20160139045A (pt)
CN (1) CN1922307A (pt)
AT (1) ATE458038T1 (pt)
AU (1) AU2004309300B8 (pt)
BR (1) BRPI0418310A (pt)
CA (1) CA2551266C (pt)
DE (1) DE602004025623D1 (pt)
RU (1) RU2006127446A (pt)
WO (1) WO2005063972A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100817020B1 (ko) * 2006-10-30 2008-03-27 건국대학교 산학협력단 셀레늄을 유효성분으로 하는 배아 발생 개선용 조성물 및그 방법
US9574173B2 (en) * 2010-11-15 2017-02-21 Accelerated Biosciences Corp. Generation of neural stem cells from human trophoblast stem cells
US10017733B2 (en) 2013-02-15 2018-07-10 Sung Kwang Medical Foundation Production of parthenogenetic stem cells and patient-specific human embryonic stem cells using somatic cell nuclear transfer
EP2997131A4 (en) * 2013-05-13 2016-10-26 Univ Oregon Health & Science HUMAN PLURIPOTENTIAL STEM CELLS MADE BY SOMATIC CELL CORE TRANSFER
US9783779B2 (en) 2013-11-27 2017-10-10 The Curators Of The University Of Missouri Artificial oocyte activation
CN108026544A (zh) 2015-07-17 2018-05-11 医疗法人圣光医疗财团 Nt细胞的贮存方法和存储系统
WO2017014513A1 (ko) * 2015-07-17 2017-01-26 의료법인 성광의료재단 Nt세포의 보관방법 및 뱅킹 시스템
US11535824B2 (en) 2015-10-29 2022-12-27 Sung Kwang Medical Foundation Nuclear transfer
CN106399229A (zh) * 2016-10-25 2017-02-15 浙江译美生物科技有限公司 一种诱导剂及采用该诱导剂制备表皮干细胞的方法
CN106754654A (zh) * 2016-12-02 2017-05-31 内蒙古大学 以干细胞为基础的哺乳动物人工胚胎构建‑动物克隆繁育的方法及其模型
CN106834207A (zh) * 2016-12-14 2017-06-13 中国水产科学研究院珠江水产研究所 一种中华鳖卵巢细胞分离及体外培养方法
CN113151158A (zh) * 2021-05-19 2021-07-23 杭州憶盛医疗科技有限公司 一种组织干细胞分离和功能评价系统
WO2023008918A1 (ko) * 2021-07-28 2023-02-02 의료법인 성광의료재단 B2m 유전자의 발현이 저해된 유전적으로 조작된 줄기세포 및 이의 이용방법
CN115927169B (zh) * 2022-10-11 2023-08-11 再造再生医学科技(杭州)有限公司 用于扩增cd34+造血干细胞的培养液和体外扩增cd34+造血干细胞的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986007377A1 (en) 1985-06-12 1986-12-18 Luminis Pty. Ltd. Culture media for in vitro fertilization and embryo transfer
AU5577600A (en) 1999-06-30 2001-01-31 Woo-Suk Hwang A method for producing human embryonic skin cells by employing an inter-species nuclear transplantation technique
JP2001017160A (ja) * 1999-07-07 2001-01-23 Fuso Pharmaceutical Industries Ltd 体外受精用培地組成物
WO2001088104A2 (en) 2000-05-17 2001-11-22 Geron Corporation Neural progenitor cell populations
WO2002086073A2 (en) * 2001-04-20 2002-10-31 Memorial Sloan-Kettering Cancer Center Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use

Also Published As

Publication number Publication date
US20110065192A1 (en) 2011-03-17
US20120083032A1 (en) 2012-04-05
EP1711599A1 (en) 2006-10-18
CN1922307A (zh) 2007-02-28
AU2004309300B2 (en) 2008-06-12
CA2551266C (en) 2011-07-26
CA2551266A1 (en) 2005-07-14
US9476064B2 (en) 2016-10-25
WO2005063972A1 (en) 2005-07-14
KR20060105041A (ko) 2006-10-09
AU2004309300A1 (en) 2005-07-14
US20140154800A1 (en) 2014-06-05
JP2007516720A (ja) 2007-06-28
EP1711599A4 (en) 2008-04-16
RU2006127446A (ru) 2008-02-10
AU2004309300B8 (en) 2009-03-26
EP1711599B1 (en) 2010-02-17
KR20160139045A (ko) 2016-12-06
ATE458038T1 (de) 2010-03-15
US8647872B2 (en) 2014-02-11
KR101680269B1 (ko) 2016-11-29
DE602004025623D1 (de) 2010-04-01
US20070243610A1 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
BRPI0418310A (pt) linhagem de células-tronco embrionárias, método de preparação da mesma, neuro-progenitor, método de preparação do mesmo e meio de cultura
AU2019268194A1 (en) Cell culture system
CY1118167T1 (el) Πρωτογενη και εγγυς ηπατικα βλαστοκυτταρα
AU2002361327A1 (en) Exogenous protein expression system in an avian system
MX2010001528A (es) Aislamiento, caracterizacion y propagacion de celulas madre de linea germinal.
DK2218776T3 (da) Dyreproteinfrit celledyrkningsmedie til dyrkning af celler
BRPI0710949A2 (pt) Método para indução de diferenciação de células tronco pluripotentes em cardiomiócitos
MX2008007654A (es) Factor de reprogramacion nuclear.
EA200800769A1 (ru) Перенос клеточных ядер
BRPI0517514A (pt) vesìculas bacterianas imunogênicas com proteìnas da membrana externa
EA200601187A1 (ru) Стволовые клетки
WO2003016507A3 (en) Generation of multipotent central nervous system stem cells
WO2006044594A3 (en) Methods for culturing mammalian taste cells
WO2009016078A3 (en) Method for culturing mammalian stem cells
Mallo Formation of the outer and middle ear, molecular mechanisms
Ankamreddy et al. Region-specific endodermal signals direct neural crest cells to form the three middle ear ossicles
WO2002076206A3 (en) Methods and compositions for cryopreservation of dissociated primary animal cells
DE60017931D1 (de) Verbesserte methode zur herstellung klonierten schweineembryos mittels somatischen zellkerntransfer
No et al. Scriptaid improves the reprogramming of donor cells and enhances canine-porcine interspecies embryo development
Hirabayashi et al. Ability of tetraploid rat blastocysts to support fetal development after complementation with embryonic stem cells
Rasmussen The epigenetics of early development: inferences from stem cells
WO2006036975A3 (en) Methods of embryo transfer
Kamikawa et al. The dynamics of X‐chromosome inactivation in mouse development
EP1254210A4 (en) METHOD FOR CLONING ANIMALS WITH TARGETED GENETIC CHANGES BY TRANSFER OF MALE OR FEMALE SOMATIC CELL CORES FROM LONG-TERM CULTURE INCLUDING ARTIFICIALLY INDUCED GENETIC CHANGES IN CORE RECEIVERS
WO2005046581A3 (en) P18 in stem cell manipulations

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: H BION CO., LTD. (KR)

Free format text: TRANSFERIDO DE: SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C12N 15/877 (2010.01), C12N 5/00 (2006.01), C12N 5

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]